Start A Thread

Rate NxThera

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment



In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position


* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.


Hot Ticker Articles

TranS1 Announces NICE Guidance for Approval of AxiaLIF in the UK's National Health System (NHS)

Medtronic to start study of CoreValve Evolut TAVR in low-risk patients

Free Job Postings on Medtechy Jobs Until 2019

Apps for New Apple Watch Get FDA Clearance - What Does it Mean

Mazor Robotics and Medtronic Gearing up for Mazor X Stealth Launch at NASS

Zimmer Biomet Gets Another FDA Warning Letter for Warsaw Plant

RTG and Diabetes Lead the Way for Medtronic in Q1

TransEnterix Earnings SWOT Analysis

NxThera Message Board

NxThera to be Acquired by Boston Scientific?

1 month ago

Game over. UroLift or Procept's AquaBeam will lead the way until BSC can fire the bad apples and get their management team in with NxThera.

Baby Daddy

3 months ago

Roy O Hanley is my baby daddy come home Roy


Cancer Spinout

3 months ago

is palmetto Medicare paying for Rezum

Roy O’Hanley

4 months ago

Pat, I understand what you mean and I'm sure he is a pro but it is spelled Mohle.

Rezum EAU Data

6 months ago

They didn't though. It's a big enough market for both companies and you can argue that Boston Scientific got NxThera on the cheap. They will grow this market big time with their urology sales team.

NxThera News

7 months ago

Mayo Clinic Radio

Steam Treatment for Benign Prostatic Hyperplasia with Dr. Tobias Kohler

Acquisition Imminent

8 months ago

Don't know who yet but talks are on going.

Don't shoot the messenger.